Skip to Main Content

Paper Details

Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Genes Chromosomes and Cancer
8
2022
(MAST) kinase, BCL2L14, CCDC170 gene fusions, ESR1, ESR1 exon 6, ESR1 exon 6 fusions, ETV6, ETV6 fusions, Fusion-associated carcinomas of the breast, HER2, HER3, MAST, MYB, MYB Proto-Oncogene, NFIB, NOTCH, NOTCH/microtubule-associated serine-threonine (MAST) kinase gene fusions, NTRK3 fusion, NTRK3 kinase, SRC, SRC Proto-Oncogene, adenoid cystic carcinomas of the breast, breast cancer, breast malignancy, cancer, estrogen, estrogen-receptor, gene fusions, luminal B and endocrine-resistant breast cancer, microtubule-associated serine-threonine, paclitaxel, patients, secretory breast carcinoma, serine, solid tumors, threonine, triple-negative subtype
Author NameAffiliation
Adrian V LeeUPMC Hillman Cancer Center, University of Pittsburgh
Adrian V LeeUniversity of Pittsburgh
Adrian V LeeUniversity of Pittsburgh
  • 1 - 3

Datasets

Release 1.2